BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25475113)

  • 1. CBMAR: a comprehensive β-lactamase molecular annotation resource.
    Srivastava A; Singhal N; Goel M; Virdi JS; Kumar M
    Database (Oxford); 2014; 2014():bau111. PubMed ID: 25475113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BlaPred: Predicting and classifying β-lactamase using a 3-tier prediction system via Chou's general PseAAC.
    Srivastava A; Kumar R; Kumar M
    J Theor Biol; 2018 Nov; 457():29-36. PubMed ID: 30138632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of β-lactamase and its class by Chou's pseudo-amino acid composition and support vector machine.
    Kumar R; Srivastava A; Kumari B; Kumar M
    J Theor Biol; 2015 Jan; 365():96-103. PubMed ID: 25454009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced identification of β-lactamases and its classes using sequence, physicochemical and evolutionary information with sequence feature characterization of the classes.
    Nath A; Karthikeyan S
    Comput Biol Chem; 2017 Jun; 68():29-38. PubMed ID: 28231526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lactamase Engineering Database: a critical survey of TEM sequences in public databases.
    Thai QK; Bös F; Pleiss J
    BMC Genomics; 2009 Aug; 10():390. PubMed ID: 19698099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis.
    Oefner C; D'Arcy A; Daly JJ; Gubernator K; Charnas RL; Heinze I; Hubschwerlen C; Winkler FK
    Nature; 1990 Jan; 343(6255):284-8. PubMed ID: 2300174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic phylogenetic classification of bacterial beta-lactamase sequences including structural and antibiotic substrate preference information.
    Ma J; Eisenhaber F; Maurer-Stroh S
    J Bioinform Comput Biol; 2013 Dec; 11(6):1343011. PubMed ID: 24372040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and biochemical characterization of VIM-12, a novel hybrid VIM-1/VIM-2 metallo-beta-lactamase from a Klebsiella pneumoniae clinical isolate, reveal atypical substrate specificity.
    Kontou M; Pournaras S; Kristo I; Ikonomidis A; Maniatis AN; Stathopoulos C
    Biochemistry; 2007 Nov; 46(45):13170-8. PubMed ID: 17944487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of group specific motifs in beta-lactamase family of proteins.
    Singh R; Saxena A; Singh H
    J Biomed Sci; 2009 Dec; 16(1):109. PubMed ID: 19954553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the serine beta-lactamases: past, present and future.
    Hall BG; Barlow M
    Drug Resist Updat; 2004 Apr; 7(2):111-23. PubMed ID: 15158767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based phylogeny of the metallo-beta-lactamases.
    Garau G; Di Guilmi AM; Hall BG
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2778-84. PubMed ID: 15980349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily.
    Bebrone C
    Biochem Pharmacol; 2007 Dec; 74(12):1686-701. PubMed ID: 17597585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic tree and sequence similarity of beta-lactamases.
    Ogawara H
    Mol Phylogenet Evol; 1993 Jun; 2(2):97-111. PubMed ID: 8025724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evolutionary classification of the metallo-beta-lactamase fold proteins.
    Aravind L
    In Silico Biol; 1999; 1(2):69-91. PubMed ID: 11471246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.
    Lahiri SD; Mangani S; Jahić H; Benvenuti M; Durand-Reville TF; De Luca F; Ehmann DE; Rossolini GM; Alm RA; Docquier JD
    ACS Chem Biol; 2015 Feb; 10(2):591-600. PubMed ID: 25406838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive coupled HPLC/electrospray mass spectrometry assay for SPM-1 metallo-beta-lactamase inhibitors.
    Sanchez PA; Toney JH; Thomas JD; Berger JM
    Assay Drug Dev Technol; 2009 Apr; 7(2):170-9. PubMed ID: 19505232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of beta-lactamases.
    Bush K
    Ciba Found Symp; 1997; 207():152-63; discussion 163-6. PubMed ID: 9189640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation and significance of clinically relevant β-lactamases.
    Bush K
    Ann N Y Acad Sci; 2013 Jan; 1277():84-90. PubMed ID: 23346859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.